| Pradeep Manoharan, | |
|
777 North St, Pittsfield, MA 01201-4147 | |
| (413) 447-2114 | |
| Not Available |
| Full Name | Pradeep Manoharan |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 14 Years |
| Location | 777 North St, Pittsfield, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174907174 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 290652 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Berkshire Medical Center | Pittsfield, MA | Hospital |
| Fairview Hospital | Great barrington, MA | Hospital |
| Baystate Medical Center | Springfield, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Berkshire Faculty Services Inc | 8224068424 | 222 |
News Archive
Children with hearing loss struggle to hear in noisy school classrooms, even with the help of hearing aids and other devices to amplify their teacher's voice. Training the brain to filter out background noise and thus understand spoken words could help the academic performance and quality of life for children who struggle to hear, but there's been little evidence that such noise training works in youngsters.
Bristol-Myers Squibb and Syngene International, India's largest contract research organization, today announced a five-year extension of their drug discovery and development collaboration in India.
Cylene Pharmaceuticals, Inc. announced today the initiation of a Phase I clinical trial of their first-in-class, oral CK2 inhibitor CX-4945 in patients with multiple myeloma. Cylene also announced the simultaneous closing of a $12 million financing with participation from existing investors including Sanderling Ventures, HBM BioVentures (Cayman) Ltd., Novartis BioVenture Fund, BioVentures Investors, Lilly Ventures, Mitsui & Co. and Morningside Venture Investments Ltd.
Prostate cancer deaths are expected to jump 17 percent this year, according to estimates based on National Cancer Institute data. The alarming 2010 statistics, just prior to Father's Day, has ZERO – The Project to End Prostate Cancer urging families to encourage Dad to get tested for the disease this Father's Day because prostate cancer is the second leading cancer among American men.
› Verified 9 days ago
| Entity Name | Berkshire Faculty Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548212939 PECOS PAC ID: 8224068424 Enrollment ID: O20050817001122 |
News Archive
Children with hearing loss struggle to hear in noisy school classrooms, even with the help of hearing aids and other devices to amplify their teacher's voice. Training the brain to filter out background noise and thus understand spoken words could help the academic performance and quality of life for children who struggle to hear, but there's been little evidence that such noise training works in youngsters.
Bristol-Myers Squibb and Syngene International, India's largest contract research organization, today announced a five-year extension of their drug discovery and development collaboration in India.
Cylene Pharmaceuticals, Inc. announced today the initiation of a Phase I clinical trial of their first-in-class, oral CK2 inhibitor CX-4945 in patients with multiple myeloma. Cylene also announced the simultaneous closing of a $12 million financing with participation from existing investors including Sanderling Ventures, HBM BioVentures (Cayman) Ltd., Novartis BioVenture Fund, BioVentures Investors, Lilly Ventures, Mitsui & Co. and Morningside Venture Investments Ltd.
Prostate cancer deaths are expected to jump 17 percent this year, according to estimates based on National Cancer Institute data. The alarming 2010 statistics, just prior to Father's Day, has ZERO – The Project to End Prostate Cancer urging families to encourage Dad to get tested for the disease this Father's Day because prostate cancer is the second leading cancer among American men.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Pradeep Manoharan, 777 North St, Pittsfield, MA 01201-4147 Ph: (413) 447-2000 | Pradeep Manoharan, 777 North St, Pittsfield, MA 01201-4147 Ph: (413) 447-2114 |
News Archive
Children with hearing loss struggle to hear in noisy school classrooms, even with the help of hearing aids and other devices to amplify their teacher's voice. Training the brain to filter out background noise and thus understand spoken words could help the academic performance and quality of life for children who struggle to hear, but there's been little evidence that such noise training works in youngsters.
Bristol-Myers Squibb and Syngene International, India's largest contract research organization, today announced a five-year extension of their drug discovery and development collaboration in India.
Cylene Pharmaceuticals, Inc. announced today the initiation of a Phase I clinical trial of their first-in-class, oral CK2 inhibitor CX-4945 in patients with multiple myeloma. Cylene also announced the simultaneous closing of a $12 million financing with participation from existing investors including Sanderling Ventures, HBM BioVentures (Cayman) Ltd., Novartis BioVenture Fund, BioVentures Investors, Lilly Ventures, Mitsui & Co. and Morningside Venture Investments Ltd.
Prostate cancer deaths are expected to jump 17 percent this year, according to estimates based on National Cancer Institute data. The alarming 2010 statistics, just prior to Father's Day, has ZERO – The Project to End Prostate Cancer urging families to encourage Dad to get tested for the disease this Father's Day because prostate cancer is the second leading cancer among American men.
› Verified 9 days ago
Jason G. Touhey, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 725 North St, Pittsfield, MA 01201 Phone: 413-496-6820 | |
Helen Majchrowski, F.N.P.-C Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 777 North St, Suite 207, Pittsfield, MA 01201 Phone: 413-499-8510 | |
Alejandro Fierro, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 725 North St, Pittsfield, MA 01201 Phone: 413-447-2000 | |
Daniel M Doyle, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 725 North St, Pulmonary Medicine, Pittsfield, MA 01201 Phone: 413-447-2695 Fax: 413-447-3111 | |
Dr. Paula Aucoin, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 777 North St, Suite 207, Pittsfield, MA 01201 Phone: 413-499-8510 | |
Roberta Theresa Erena, MD FACC Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 777 North St, Cardiology, Pittsfield, MA 01201 Phone: 413-395-7580 Fax: 413-499-8539 | |
Dr. Pamela Miller, Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 777 North St, Suite 207, Pittsfield, MA 01201 Phone: 413-499-8510 |